Novel Kv1.3 blockers for immunosuppression: WO2012155199

被引：2
|
作者：
William Nguyen [1 ]
机构：
[1] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2013年 / 23卷 / 11期
关键词：
autoimmune disorder; Kv1.3; MS; potassium channel; psoriasis; rheumatoid arthritis; GATED POTASSIUM CHANNEL; MEMORY T-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ION-CHANNEL; K+ CHANNELS; DERIVATIVES; IMMUNOMODULATION; KHELLINONE; ACTIVATION;
D O I：
10.1517/13543776.2013.831072
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A recent patent application from Bionomics/Merck Serono describes novel compounds as blockers of the voltage-gated Kv1.3 ion channel. The blockade of this channel shows great promise as a new therapeutic target for the treatment of autoimmune disorders such as multiple sclerosis, psoriasis, diabetes and rheumatoid arthritis. The generic claim of this patent refers to a new chemotype of Kv1.3 blockers based on an amide core with potent IC50's which are potentially within the nanomolar range. This article briefly reviews the chemistry and biology found in the patent and compares it with previous discoveries in the field.
引用
收藏
页码：1511 / 1516
页数：6
相关论文
共 50 条
  • [21] Regulation of Kv1.3 activity in human T lymphocytes: peptide blockers and molecular interactions
    不详
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2005, 34 (06): : 531 - 531
  • [22] Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation a pilot study
    Hautz, Theresa
    Krapf, Christoph
    Grahammer, Johanna
    Zelger, Bettina
    Hickethier, Tilman
    Seger, Christoph
    Eberhart, Nadine
    Wallner, Christoph
    Messner, Franka
    Kotsch, Katja
    Griesmacher, Andrea
    Brandacher, Gerald
    Lee, W. P. Andrew
    Margreiter, Raimund
    Pratschke, Johann
    Glossmann, Hartmut
    Schneeberger, Stefan
    TRANSPLANT INTERNATIONAL, 2013, 26 (05) : 552 - 561
  • [23] Blockers of Kv1.3 channel suppress smooth muscle response to injury and neointimal hyperplasia
    Cheong, Alex
    Sukumar, Piruthivi
    Kumar, Bhaksar
    Li, Jing
    Bingham, Andrew J.
    Zeng, Fanning
    Munsch, Christopher
    Porter, Karen E.
    Wood, Fan C.
    Beech, David J.
    FASEB JOURNAL, 2007, 21 (05): : A69 - A69
  • [24] Kv1.3 Channel Expressing Brain Myeloid Cells are a Unique Pro-Inflammatory Subset of Microglia Which Can Be Modulated by Kv1.3 Blockers in Alzheimer's Pathology
    Ramesha, Supriya
    Gao, Tianwen
    Giver, Cynthia
    Rayaprolu, Sruti
    Nwabueze, Ngozi
    Engstorm, Amanda
    Xiao, Hailian
    Pennati, Andrea
    Katz, David
    Waller, Edmund K.
    Levey, Allan I.
    Rangaraju, Srikant
    ANNALS OF NEUROLOGY, 2020, 88 : S109 - S110
  • [25] Deciphering the Kv1.3/Caveolin Interaction
    Perez-Verdaguer, Mireia
    Capera, Jesusa
    Martinez-Marmol, Ramon
    Camps, Marta
    Comes, Nuria
    Tamkun, Michael M.
    Felipe, Antonio
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 252A - 252A
  • [26] Anomalous inactivation of a Kv1.3 mutant
    Panyi, G
    Deutsch, C
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : MPOS3 - MPOS3
  • [27] The Mitochondrial Routing of the Kv1.3 Channel
    Capera, Jesusa
    Navarro-Perez, Maria
    Moen, Anne Stine
    Szabo, Ildiko
    Felipe, Antonio
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Immunosuppressive effects of a Kv1.3 inhibitor
    Shah, K
    Blake, JT
    Huang, C
    Fischer, P
    Koo, GC
    CELLULAR IMMUNOLOGY, 2003, 221 (02) : 100 - 106
  • [29] Characterization of a novel high-selectivity Kv1.3 inhibitor peptide
    Csoti, A.
    Panyi, G.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2017, 46 : S264 - S264
  • [30] MEDI 569-Small molecule blockers of the Kv1.3 ion channel as potential immunosuppressants
    Harvey, Andrew J.
    Baell, Jonathan B.
    Cianci, Julia
    Homerick, Daniel
    Mould, Jorgen
    Toovey, Nathan L.
    Wulff, Heike
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
12345